Backing a
Healthier
Tomorrow

2024-11-18

Quanta Dialysis Secures New Funding

Medical Device
Diagnostics
Life Science Tools
HealthTech

Growth & Early
commercialization

Transforming cutting-edge medtech innovators into market leaders, through a combination of in-house expertise and an extensive network of skilled professionals

  • Investment stage Growth & Commercialization
  • Geographies Europe, with a Nordic focus
  • Investsment focus Medical Devices, Diagnostics, Life Science Tools, and HealthTech
  • Assets under management SEK 1.3b (~EUR 120m)
  • Ticket size SEK 20-150m (~EUR 2-5m)
  • Portfolio companies 9

 

 

 

 

Meet the team!

Read more

Check out of portfolio companies

Read more
2024-10-24

Jenny Sundqvist appointed CEO of Navinci
2024-09-06

CytaCoat and Absorbest announce development and licensing agreement for superabsorbent advanced wound care dressings
2023-09-28

Segulah Medical Acceleration announces investment in Senzime
2023-08-28

Collective Minds Radiology announces closing of SEK 84m financing, led by Segulah Medical Acceleration and existing shareholders
2023-02-20

Navinci appoints Eva Pisa as chairman, further strengthens the leadership team and establishes a Scientific Advisory Board